• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊髓液神经丝轻链蛋白水平在额颞叶痴呆亚型中的变化。

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.

机构信息

Section of Geriatric Psychiatry, Department of Clinical Sciences, Lund University Hospital, Klinikgatan 22, Lund SE-221 85, Sweden.

出版信息

BMC Neurol. 2013 May 29;13:54. doi: 10.1186/1471-2377-13-54.

DOI:10.1186/1471-2377-13-54
PMID:23718879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3671150/
Abstract

BACKGROUND

Frontotemporal dementia (FTD) is recognised as a clinically and morphologically heterogeneous group of interrelated neurodegenerative conditions. One of the subtypes within this disease spectrum is the behavioural variant FTD (bvFTD). This is known to be a varied disorder with a mixture of tau-positive and tau-negative underlying pathologies. The other subtypes include semantic dementia (SD), which generally exhibits tau-negative pathology, and progressive non-fluent aphasia (PNFA), which is usually tau-positive. As the clinical presentation of these subtypes may overlap, a specific diagnosis can be difficult to attain and today no specific biomarker can predict the underlying pathology. Neurofilament light chain protein (NFL), a cytoskeletal constituent of intermediate filaments, is thought to reflect neuronal and axonal death when appearing in the cerebrospinal fluid (CSF). NFL has been shown to be elevated in CSF in patients with FTD compared with AD and controls. Our hypothesis was that the levels of NFL also differ between the subtypes of FTD and may indicate the underlying pathological subtype.

METHODS

We retrospectively analysed data from previous CSF analyses in 34 FTD cases (23 bvFTD, seven SD, four PNFA), 20 AD cases, and 26 healthy controls. A separate group of 10 neuropathologically verified and subtyped FTD cases (seven tau-negative, three tau-positive) were also analysed.

RESULT

NFL levels were significantly higher in FTD compared with both AD (p<0.001) and controls (p<0.001). The NFL levels of SD and bvFTD were significantly higher (p<0.001) compared with AD. The biomarker profiles of PNFA and AD were similar. In the neuropathologically verified FTD cases, NFL was higher in the tau-negative than in the tau-positive cases (exact p=0.017).

CONCLUSIONS

The marked NFL elevation in some but not all FTD cases is likely to reflect the different underlying pathologies. The highest NFL values found in the SD group as well as in the neuropathologically verified tau-negative cases may be of subtype diagnostic value, if corroborated in larger patient cohorts. In bvFTD, a mixture of tau-positive and tau-negative underlying pathologies could possibly explain the intermediate NFL values.

摘要

背景

额颞叶痴呆(FTD)被认为是一组具有临床和形态学异质性的相关神经退行性疾病。该病谱中的一个亚型是行为变异型额颞叶痴呆(bvFTD)。这种疾病表现多样,既有 tau 阳性也有 tau 阴性的潜在病理。其他亚型包括语义性痴呆(SD),通常表现为 tau 阴性病理,以及进行性非流利性失语症(PNFA),通常为 tau 阳性。由于这些亚型的临床表现可能重叠,因此很难做出特定的诊断,目前也没有特定的生物标志物可以预测潜在的病理。神经丝轻链蛋白(NFL)是中间丝的细胞骨架成分,当出现在脑脊液(CSF)中时,被认为反映了神经元和轴突的死亡。与 AD 和对照组相比,FTD 患者的 CSF 中 NFL 升高。我们的假设是,FTD 各亚型之间的 NFL 水平也不同,可能表明潜在的病理亚型。

方法

我们回顾性分析了 34 例 FTD 病例(23 例 bvFTD、7 例 SD、4 例 PNFA)、20 例 AD 病例和 26 例健康对照的 CSF 分析数据。还分析了一组 10 例经神经病理学证实并分型的 FTD 病例(7 例 tau 阴性,3 例 tau 阳性)。

结果

FTD 患者的 NFL 水平明显高于 AD(p<0.001)和对照组(p<0.001)。SD 和 bvFTD 的 NFL 水平明显高于 AD(p<0.001)。PNFA 和 AD 的生物标志物谱相似。在神经病理学证实的 FTD 病例中,tau 阴性病例的 NFL 水平高于 tau 阳性病例(确切 p=0.017)。

结论

一些而非所有 FTD 病例中明显的 NFL 升高可能反映了不同的潜在病理。在 SD 组以及神经病理学证实的 tau 阴性病例中发现的最高 NFL 值可能具有亚型诊断价值,如果在更大的患者队列中得到证实。在 bvFTD 中,tau 阳性和 tau 阴性潜在病理的混合可能可以解释中间 NFL 值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bec/3671150/f63ca1fce252/1471-2377-13-54-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bec/3671150/d3de8caf833f/1471-2377-13-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bec/3671150/f63ca1fce252/1471-2377-13-54-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bec/3671150/d3de8caf833f/1471-2377-13-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bec/3671150/f63ca1fce252/1471-2377-13-54-2.jpg

相似文献

1
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.脑脊髓液神经丝轻链蛋白水平在额颞叶痴呆亚型中的变化。
BMC Neurol. 2013 May 29;13:54. doi: 10.1186/1471-2377-13-54.
2
Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.额颞叶痴呆谱系患者的脑脊液生物标志物:一项单中心研究。
J Alzheimers Dis. 2018;66(2):551-563. doi: 10.3233/JAD-180409.
3
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.脑脊髓液神经丝轻链蛋白水平与痴呆、运动神经元病和运动障碍患者认知的相关性。
JAMA Neurol. 2019 Mar 1;76(3):318-325. doi: 10.1001/jamaneurol.2018.3746.
4
Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.神经丝和磷酸化 tau/总 tau 比值在额颞叶痴呆谱中的临床价值。
Neurology. 2018 Apr 3;90(14):e1231-e1239. doi: 10.1212/WNL.0000000000005261. Epub 2018 Mar 7.
5
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.脑脊液可溶性 TREM2 水平在额颞叶痴呆的遗传和病理亚组中存在差异。
Alzheimers Res Ther. 2018 Aug 16;10(1):79. doi: 10.1186/s13195-018-0405-8.
6
Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.脑脊液神经丝浓度反映额颞叶变性的疾病严重程度。
Ann Neurol. 2014 Jan;75(1):116-26. doi: 10.1002/ana.24052. Epub 2014 Jan 2.
7
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.阿尔茨海默病鉴别诊断中的脑脊液:在专科认知诊所中扩展生物标志物组合的临床效用。
Alzheimers Res Ther. 2018 Mar 20;10(1):32. doi: 10.1186/s13195-018-0361-3.
8
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.快速进展性神经退行性痴呆症中的 CSF 神经丝轻链特征。
Alzheimers Res Ther. 2018 Jan 11;10(1):3. doi: 10.1186/s13195-017-0331-1.
9
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.采用 6 种联合脑脊液候选物(Aβ、总tau、磷酸化tau、NFL、神经颗粒蛋白和 YKL-40)的阿尔茨海默病生物标志物指导诊断工作流程。
Alzheimers Dement. 2018 Apr;14(4):492-501. doi: 10.1016/j.jalz.2017.11.015. Epub 2018 Jan 9.
10
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.脑脊液神经丝轻链可区分行为变异型额颞叶痴呆的进展者和非进展者。
J Neurol Sci. 2022 Nov 15;442:120439. doi: 10.1016/j.jns.2022.120439. Epub 2022 Sep 30.

引用本文的文献

1
The relationship between mixed exposure to blood metal and serum neurofilament light chain levels in the general U.S. population: an unsupervised clustering approach.美国普通人群中血液金属混合暴露与血清神经丝轻链水平之间的关系:一种无监督聚类方法。
Front Public Health. 2025 Jul 30;13:1516879. doi: 10.3389/fpubh.2025.1516879. eCollection 2025.
2
Distinctive autophagy/mitophagy biomarker profiles in frontotemporal lobar degeneration and Alzheimer's disease.额颞叶痴呆和阿尔茨海默病中独特的自噬/线粒体自噬生物标志物谱。
Acta Neuropathol Commun. 2025 Feb 20;13(1):37. doi: 10.1186/s40478-025-01954-9.
3
Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers.

本文引用的文献

1
The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study.血管危险因素作用下与年龄相关的脑白质改变的空间分布:LADIS 研究结果。
Neuroimage. 2012 Apr 15;60(3):1597-607. doi: 10.1016/j.neuroimage.2012.01.106. Epub 2012 Jan 28.
2
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.帕金森综合征中的淀粉样相关生物标志物和轴突损伤蛋白。
Parkinsonism Relat Disord. 2012 Jan;18(1):69-72. doi: 10.1016/j.parkreldis.2011.08.012. Epub 2011 Aug 27.
3
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
多聚体检测系统:一种用于区分蛋白质寡聚体和单体的通用检测系统。
Int J Mol Sci. 2025 Jan 30;26(3):1199. doi: 10.3390/ijms26031199.
4
A turn-on fluorescent immunosensor for neurodegenerative disease related neurofilament light chain protein.一种用于神经退行性疾病相关神经丝轻链蛋白的开启型荧光免疫传感器。
Mikrochim Acta. 2025 Feb 4;192(3):131. doi: 10.1007/s00604-025-06995-4.
5
Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates.神经退行性痴呆中的神经丝轻链:影像学相关性综述
Brain Sci. 2024 Mar 13;14(3):272. doi: 10.3390/brainsci14030272.
6
Textural and Volumetric Changes of the Temporal Lobes in Semantic Variant Primary Progressive Aphasia and Alzheimer's Disease.颞叶的纹理和容积变化在语义变异原发性进行性失语症和阿尔茨海默病中的表现。
J Korean Med Sci. 2023 Oct 23;38(41):e316. doi: 10.3346/jkms.2023.38.e316.
7
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants.ALS-FTD 连续体中的神经炎症途径:关注遗传变异。
Genes (Basel). 2023 Aug 21;14(8):1658. doi: 10.3390/genes14081658.
8
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.神经丝轻链、神经胶质纤维酸性蛋白和神经元五聚素-2 的联合检测可区分额颞叶痴呆和其他类型痴呆。
J Alzheimers Dis. 2022;90(1):363-380. doi: 10.3233/JAD-220318.
9
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?神经退行性疾病的病理生理学:轴突运输失败、氧化应激和炎症之间的相互作用?
Semin Immunol. 2022 Jan;59:101628. doi: 10.1016/j.smim.2022.101628. Epub 2022 Jun 30.
10
New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia.基于生物流体的生物标志物在额颞叶痴呆的常规诊断和疾病轨迹中的新进展。
Alzheimers Dement. 2022 Nov;18(11):2292-2307. doi: 10.1002/alz.12643. Epub 2022 Mar 2.
修订后的额颞叶痴呆行为变异型诊断标准的敏感性。
Brain. 2011 Sep;134(Pt 9):2456-77. doi: 10.1093/brain/awr179. Epub 2011 Aug 2.
4
Neuropathological background of phenotypical variability in frontotemporal dementia.额颞叶痴呆表型变异性的神经病理学背景。
Acta Neuropathol. 2011 Aug;122(2):137-53. doi: 10.1007/s00401-011-0839-6. Epub 2011 May 26.
5
Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.新型额颞叶痴呆:超越 tau 和 TDP-43。
J Mol Neurosci. 2011 Nov;45(3):402-8. doi: 10.1007/s12031-011-9551-1. Epub 2011 May 21.
6
Classification of primary progressive aphasia and its variants.原发性进行性失语症及其变体的分类。
Neurology. 2011 Mar 15;76(11):1006-14. doi: 10.1212/WNL.0b013e31821103e6. Epub 2011 Feb 16.
7
Biomarkers in Alzheimer's disease drug development.阿尔茨海默病药物研发中的生物标志物。
Nat Med. 2010 Nov;16(11):1218-22. doi: 10.1038/nm.2221. Epub 2010 Sep 21.
8
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.FUS 病理学定义了大多数 tau 和 TDP-43 阴性额颞叶变性。
Acta Neuropathol. 2010 Jul;120(1):33-41. doi: 10.1007/s00401-010-0698-6. Epub 2010 May 20.
9
Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液和血清中神经丝抗体。
Eur J Neurol. 2010 Apr;17(4):562-6. doi: 10.1111/j.1468-1331.2009.02853.x. Epub 2009 Nov 24.
10
A new subtype of frontotemporal lobar degeneration with FUS pathology.具有 FUS 病理学特征的额颞叶变性的一个新亚型。
Brain. 2009 Nov;132(Pt 11):2922-31. doi: 10.1093/brain/awp214. Epub 2009 Aug 11.